Metreleptin
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Metreleptin, covering 2016-08-16 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD) [Phase 3]